Clinical Applications of Cost Analysis of Diabetic Macular Edema Treatments
- 1 December 2012
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 119 (12) , 2558-2562
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular EdemaArchives of Ophthalmology (1950), 2009
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- Rosiglitazone and Delayed Onset of Proliferative Diabetic RetinopathyArchives of Ophthalmology (1950), 2008
- Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialThe Lancet, 2007
- Effect of Ruboxistaurin in Patients With Diabetic Macular EdemaArchives of Ophthalmology (1950), 2007
- A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular EdemaOphthalmology, 2005
- Progression of Retinopathy with Intensive versus Conventional Treatment in the Diabetes Control and Complications TrialOphthalmology, 1995
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVOphthalmology, 1995
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985